Image Image Image Image Image Image Image Image Image Image

| August 24, 2017

Scroll to top

Top

No Comments

Editas Medicine opens above issue price in its market debut

Editas Medicine opens above issue price in its market debut
Editas Medicine Inc. EDIT, +13.75% a genome editing company, opened at $ 18 in its debut on the Nasdaq Wednesday. Editas sold 5.9 million shares at an issue price of $ 16, to raise $ 94.4 million. Shares were trading at $ 16.57 after the stock started trading.
Read more on MarketWatch


Chopra, Tanzi: Devices Will Reduce Disease, Alter Medicine
LAS VEGAS β€” Personal electronic devices that spot early signs of disease, monitor and encourage fitness, and lower stress can help people reprogram their DNA for a healthier life, celebrity physicians said here at the Consumer Technology Association …
Read more on Medscape


The hidden costs of the financial conflict of interest in medicine
In a paper published in the current issue of Psychotherapy and Psychosomatics, Giovanni A. Fava, MD, provides an analysis of some subtle and yet important consequences of financial conflicts of interest in medicine. He also strongly criticizes the …
Read more on Medical Xpress

Related posts:

Submit a Comment